These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1505 related articles for article (PubMed ID: 16928527)
1. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Bryant AS; Cerfolio RJ Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527 [TBL] [Abstract][Full Text] [Related]
2. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules. Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584 [TBL] [Abstract][Full Text] [Related]
3. Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer. Bryant AS; Cerfolio RJ; Klemm KM; Ojha B Ann Thorac Surg; 2006 Aug; 82(2):417-22; discussion 422-3. PubMed ID: 16863739 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules. Tsushima Y; Tateishi U; Uno H; Takeuchi M; Terauchi T; Goya T; Kim EE Ann Nucl Med; 2008 Aug; 22(7):571-7. PubMed ID: 18756359 [TBL] [Abstract][Full Text] [Related]
5. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET. Hickeson M; Yun M; Matthies A; Zhuang H; Adam LE; Lacorte L; Alavi A Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1639-47. PubMed ID: 12458399 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of primary pulmonary carcinoid tumors using FDG PET. Erasmus JJ; McAdams HP; Patz EF; Coleman RE; Ahuja V; Goodman PC AJR Am J Roentgenol; 1998 May; 170(5):1369-73. PubMed ID: 9574618 [TBL] [Abstract][Full Text] [Related]
7. Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT). Turan O; Ozdogan O; Gurel D; Onen A; Kargi A; Sevinc C Clin Respir J; 2013 Jan; 7(1):e1-5. PubMed ID: 22129499 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Nomori H; Watanabe K; Ohtsuka T; Naruke T; Suemasu K; Uno K Lung Cancer; 2004 Jul; 45(1):19-27. PubMed ID: 15196730 [TBL] [Abstract][Full Text] [Related]
9. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441 [TBL] [Abstract][Full Text] [Related]
10. Fluoro-deoxy-glucose positron emission tomography for evaluation of indeterminate lung nodules: assigning a probability of malignancy may be preferable to binary readings. Kim SC; Machac J; Krynyckyi BR; Knesaurek K; Krellenstein D; Schultz B; Gribetz A; DePalo L; Teirstein A; Kim CK Ann Nucl Med; 2008 Apr; 22(3):165-70. PubMed ID: 18498030 [TBL] [Abstract][Full Text] [Related]
11. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT. Chun EJ; Lee HJ; Kang WJ; Kim KG; Goo JM; Park CM; Lee CH Lung Cancer; 2009 Aug; 65(2):180-6. PubMed ID: 19155090 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of PET/CT in differentiating benign from malignant solitary pulmonary nodules. Dalli A; Selimoglu Sen H; Coskunsel M; Komek H; Abakay O; Sergi C; Cetin Tanrikulu A J BUON; 2013; 18(4):935-41. PubMed ID: 24344020 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the solitary pulmonary nodule: 18F-FDG PET versus nodule-enhancement CT. Christensen JA; Nathan MA; Mullan BP; Hartman TE; Swensen SJ; Lowe VJ AJR Am J Roentgenol; 2006 Nov; 187(5):1361-7. PubMed ID: 17056930 [TBL] [Abstract][Full Text] [Related]
14. Ratio of the maximum standardized uptake value on FDG-PET of the mediastinal (N2) lymph nodes to the primary tumor may be a universal predictor of nodal malignancy in patients with nonsmall-cell lung cancer. Cerfolio RJ; Bryant AS Ann Thorac Surg; 2007 May; 83(5):1826-9; discussion 1829-30. PubMed ID: 17462407 [TBL] [Abstract][Full Text] [Related]
15. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas. Okada M; Tauchi S; Iwanaga K; Mimura T; Kitamura Y; Watanabe H; Adachi S; Sakuma T; Ohbayashi C J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1448-54. PubMed ID: 17532938 [TBL] [Abstract][Full Text] [Related]
16. Limitations of dual time point PET in the assessment of lung nodules with low FDG avidity. Cloran FJ; Banks KP; Song WS; Kim Y; Bradley YC Lung Cancer; 2010 Apr; 68(1):66-71. PubMed ID: 19559496 [TBL] [Abstract][Full Text] [Related]
17. 18-fluorine fluorodeoxyglucose positron emission tomography with computerized tomography versus computerized tomography alone for the management of solitary lung nodules with diameters inferior to 1.5 cm. Divisi D; Di Tommaso S; Di Leonardo G; Brianzoni E; De Vico A; Crisci R Thorac Cardiovasc Surg; 2010 Oct; 58(7):422-6. PubMed ID: 20922626 [TBL] [Abstract][Full Text] [Related]
18. Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5. Chen CJ; Lee BF; Yao WJ; Cheng L; Wu PS; Chu CL; Chiu NT AJR Am J Roentgenol; 2008 Aug; 191(2):475-9. PubMed ID: 18647920 [TBL] [Abstract][Full Text] [Related]
19. Respiratory-gated imaging in metabolic evaluation of small solitary pulmonary nodules: 18F-FDG PET/CT and correlation with histology. Farid K; Poullias X; Alifano M; Regnard JF; Servois V; Caillat-Vigneron N; Petras S Nucl Med Commun; 2015 Jul; 36(7):722-7. PubMed ID: 25793929 [TBL] [Abstract][Full Text] [Related]
20. FDG PET/CT evaluation of pathologically proven pulmonary lesions in an area of high endemic granulomatous disease. Sebro R; Aparici CM; Hernandez-Pampaloni M Ann Nucl Med; 2013 May; 27(4):400-5. PubMed ID: 23400394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]